CRISPR-Cas systems are prokaryotic immune systems that confer resistance to foreign genetic elements such as plasmids and phages. CRISPR-Cas systems have been exploited for targeted genome editing.
Briefing.com uses cookies to operate the site, maintain security, remember preferences, and provide subscription features. These cookies are necessary to use Briefing.com. We also use optional ...